The role of private equity (PE) in ophthalmology has shifted the practice landscape during the past 10 years. While proponents of PE investment tout the benefit of extra access to capital and resources, critics fear that these partnerships lead to a loss of autonomy and potential risk to patient care. In this episode, Drs. Dagny Zhu, Omar Shakir, and Ravi Parikh review the current published data about PE in ophthalmology and share their personal perspectives on its real-world impact on clinical practice.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Paul Gaudio and Ninani Kombo join Dr. Ben Young to review pearls and common challenges in the diagnosis and treatment of intermediate uveitis.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Anita Kohli and Imran Jivraj discuss the evaluation and treatment of isolated third, fourth, and sixth cranial nerve palsies, including when to order testing and imaging. 

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Amanda Redfern speaks with Drs. Maggie Hymowitz and Donna Kim about the role of the ophthalmic hospitalist, a burgeoning profession in ophthalmology with increased demand. The discussion ranges from how to get started in the field, benefits and challenges of the role, and future directions.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Ben Young takes the reigns as host, welcoming Drs. Pavlina Kemp and Roni Levin to discuss tips and tricks—and pitfalls to avoid—when seeing and managing patients with neurocognitive developmental delay.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

In this second half of a discussion on secondary IOLs, Drs. Brenton Finklea and Fasika Woreta rejoin the show to talk about the benefits and risks of scleral-fixated and scleral-sutured IOLs, and surgical techniques for improving their safety and effectiveness.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Brian Do shares his diagnostic and therapeutic approach to herpetic uveitis, from the front of the eye to the back. Discussion ranges from anterior uveitis to acute retinal necrosis, including surgical management from the perspective of a retinal surgeon.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Sarah Read, M. Ali Khan, and Ajay Kuriyan join a group discussion on incorporating newly approved medications into practice, focusing on real-world examples of Vuity (pilocarpine drops), brolucizumab, and drugs for dry AMD in trial.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Pavlina Kemp and Matthew Weed discuss 2 recent publications in major ophthalmology journals: the first examining strabismus surgery patterns in an IRIS Registry study, and the second evaluating the association between outdoor activity and myopia progression.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.